Assessing combined methylation-sensitive high resolution melting and pyrosequencing for the analysis of heterogeneous DNA methylation

Epigenetics

Volumn 6, Issue 4, 2011, Pages 500-507

  Candiloro, Ida L M ^a,b   Mikeska, Thomas ^a,b   Dobrovic, Alexander ^a,b  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Chronic lymphocytic leukemia; DAPK1; Digital PCR; Heterogeneous DNA methylation; MS HRM; Pyrosequencing

Indexed keywords

AGAROSE; BISULFITE; DNA; APOPTOSIS REGULATORY PROTEIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE; DEATH-ASSOCIATED PROTEIN KINASE; HYDROGEN SULFITE; SULFITE;

ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; GENETIC PROCEDURES; HUMAN; METHYLATION SENSITIVE HIGH RESOLUTION MELTING; PYROSEQUENCING; QUALITY CONTROL; TUMOR SUPPRESSOR GENE; BIOTINYLATION; CHEMISTRY; DNA SEQUENCE; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE; PHASE TRANSITION; POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE;

APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; BIOTINYLATION; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASES; DNA; DNA METHYLATION; GENETIC TECHNIQUES; HUMANS; PHASE TRANSITION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SULFITES; TUMOR CELLS, CULTURED;

EID: 79954526429     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.6.4.14853     Document Type: Article

References (35)

1. Laird PW. The power and the promise of DNA methylation markers. Nat Rev Cancer 2003; 3:253-66.
2. Levenson VV. Biomarkers for early detection of breast cancer: what, when and where? Biochim Biophys Acta 2007; 1770:847-56.
3. Dodge JE, List AF, Futscher BW. Selective variegated methylation of the p15 CpG island in acute myeloid leukemia. Int J Cancer 1998; 78:561-7.
4. Aggerholm A, Hokland P. DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology? Blood 2000; 95:2997-9.
5. Costello JF, Futscher BW, Tano K, Graunke DM, Pieper RO. Graded methylation in the promoter and body of the O6-methylguanine DNA methyltransferase (MGMT) gene correlates with MGMT expression in human glioma cells. J Biol Chem 1994; 269:17228-37.
6. Versmold B, Felsberg J, Mikeska T, Ehrentraut D, Kohler J, Hampl JA. Epigenetic silencing of the candidate tumor suppressor gene PROX1 in sporadic breast cancer. Int J Cancer 2007; 121:547-54.
7. Wolf I, Bose S, Desmond JC, Lin BT, Williamson EA, Karlan BY. Unmasking of epigenetically silenced genes reveals DNA promoter methylation and reduced expression of PTCH in breast cancer. Breast Cancer Res Tr 2007; 105:139-55.
8. Mikeska T, Candiloro ILM, Dobrovic A. The implications of heterogeneous DNA methylation for the accurate quantification of methylation. Epigenomics 2010; 2:561-73.
9. Wojdacz TK, Dobrovic A. Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation. Nucleic Acids Res 2007; 35:e41.
10. Candiloro IL, Mikeska T, Hokland P, Dobrovic A. Rapid analysis of heterogeneously methylated DNA using digital methylation-sensitive high resolution melting: application to the CDKN2B (p15) gene. Epigenetics Chromatin 2008; 1:7.
11. Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites. BioTechniques 2003; 35:146-50.
12. Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. BioTechniques 2003; 35:152-6.
13. Uhlmann K, Brinckmann A, Toliat MR, Ritter H, Nurnberg P. Evaluation of a potential epigenetic biomarker by quantitative methyl-single nucleotide polymorphism analysis. Electrophoresis 2002; 23:4072-9.
14. Brakensiek K, Wingen LU, Langer F, Kreipe H, Lehmann U. Quantitative high-resolution CpG island mapping with Pyrosequencing reveals disease-specific methylation patterns of the CDKN2B gene in myelodysplastic syndrome and myeloid leukemia. Clin Chem 2007; 53:17-23.
15. Dunn J, Baborie A, Alam F, Joyce K, Moxham M, Sibson R. Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy. Br J Cancer 2009; 101:124-31.
16. Mikeska T, Bock C, El-Maarri O, Hubner A, Ehrentraut D, Schramm J. Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulfite restriction analysis. J Mol Diagn 2007; 9:368-81.
17. Tost J, Gut IG. DNA methylation analysis by pyrosequencing. Nat Protoc 2007; 2:2265-75.
18. Wojdacz TK, Dobrovic A, Hansen LL. Methylation-sensitive high-resolution melting. Nat Protoc 2008; 3:1903-8.
19. Raval A, Tanner SM, Byrd JC, Angerman EB, Perko JD, Chen SS. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007; 129:879-90.
20. Kawaguchi K, Oda Y, Saito T, Yamamoto H, Takahira T, Tamiya S. Death-associated protein kinase (DAP kinase) alteration in soft tissue leiomyosarcoma: Promoter methylation or homozygous deletion is associated with a loss of DAP kinase expression. Hum Pathol 2004; 35:1266-71.
21. Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 2001; 61:939-42.
22. Satoh A, Toyota M, Itoh F, Kikuchi T, Obata T, Sasaki Y. DNA methylation and histone deacetylation associated with silencing DAP kinase gene expression in colorectal and gastric cancers. Br J Cancer 2002; 86:1817-23.
23. Wong TS, Chang HW, Tang KC, Wei WI, Kwong DL, Sham JS. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients. Clin Cancer Res 2002; 8:433-7.
24. Katzenellenbogen RA, Baylin SB, Herman JG. Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 1999; 93:4347-53.
25. Seeliger B, Wilop S, Osieka R, Galm O, Jost E. CpG island methylation patterns in chronic lymphocytic leukemia. Leukemia Lymphoma 2009; 50:419-26.
26. Rossi D, Capello D, Gloghini A, Franceschetti S, Paulli M, Bhatia K. Aberrant promoter methylation of multiple genes throughout the clinico-pathologic spectrum of B-cell neoplasia. Haematologica 2004; 89:154-64.
27. Gharizadeh B, Nordstrom T, Ahmadian A, Ronaghi M, Nyren P. Long-read pyrosequencing using pure 2'-deoxyadenosine-5'-O'-(1-thiotriphosphate) Sp-isomer. Anal Biochem 2002; 301:82-90.
28. Kristensen LS, Wojdacz TK, Thestrup BB, Wiuf C, Hager H, Hansen LL. Quality assessment of DNA derived from up to 30 years old formalin fixed paraffin embedded (FFPE) tissue for PCR-based methylation analysis using SMART-MSP and MS-HRM. BMC Cancer 2009; 9:453.
29. Wong N, Morley R, Saffery R, Craig J. Archived Guthrie blood spots as a novel source for quantitative DNA methylation analysis. BioTechniques 2008; 45:423-4.
30. Tost J, El abdalaoui H, Gut IG. Serial pyrosequencing for quantitative DNA methylation analysis. BioTechniques 2006; 40:721-2.
31. Warnecke PM, Stirzaker C, Melki JR, Millar DS, Paul CL, Clark SJ. Detection and measurement of PCR bias in quantitative methylation analysis of bisulphite-treated DNA. Nucleic Acids Res 1997; 25:4422-6.
32. Warnecke PM, Stirzaker C, Song J, Grunau C, Melki JR, Clark SJ. Identification and resolution of artifacts in bisulfite sequencing. Methods 2002; 27: 101-7.
33. Kristensen LS, Mikeska T, Krypuy M, Dobrovic A. Sensitive Melting Analysis after Real Time-Methylation Specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection. Nucleic Acids Res 2008; 36:e42.
34. Candiloro IL, Dobrovic A. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev Res 2009; 2:862-7.
35. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 2005; 21:4067-8.